Global Cause
In this issue
-
s Sponsored
The overlooked link between animals, antibiotics and investment risks
Blame for antibiotic overuse is usually laid on doctors writing unnecessary prescriptions or patients failing to follow instructions. Little attention has been paid to the world’s single biggest consumer of these vital drugs: intensive animal agriculture. Every year, billions of cows, pigs and poultry are routinely injected with the same antibiotics on which human health...
-
s Sponsored
How to translate AMR awareness into decisive strategies and efficient solutions
Antimicrobial resistance (AMR) to antibiotics is one of the three most critical threats to patients’ lives, and it continues to grow on a global scale. Published data by the World Health Organization indicates that bacterial AMR is associated with 4.95 million deaths worldwide, with 1.27 million of those deaths directly attributable to AMR. Failure to...
-
s Sponsored
Precision antibiotic use to tackle antimicrobial resistance
A new study is aiming to help combat antimicrobial resistance by identifying ways to better tailor antibiotic prescribing to individual patients. Current antibiotic prescribing focuses on a ‘one-size-fits-all’ approach and does not account for the differences in antibiotic drug concentration that similar antibiotic doses achieve within individual patients. That, according to Dr Timothy Rawson from...
-
s Sponsored
AMR isn’t a silent pandemic — it’s screaming incredibly loudly
The world needs to wake up to the threat of AMR, says the Founder and CEO of a biopharma company dedicated to the research and development of novel antibacterial products. Antimicrobial resistance (AMR) has been called ‘the silent pandemic.’ This is ironic, notes Dr Marc Gitzinger, Founder and CEO of BioVersys, a biopharmaceutical company focusing...
-
s Sponsored
Optimising antimicrobial use in humans — a global effort
Researchers based across five international hubs are working on a unique collaboration they hope will help address the growing threat of antimicrobial resistance. A global network has been established to find new ways of making more effective use of existing antibiotics. The hope is that the Centres for Antimicrobial Optimisation Network (CAMO-Net) will also help...
-
s Sponsored
Supporting researchers to find next-generation antimicrobials
Investment and support of academic research and SMEs could prove a pivotal step in mitigating the global threat of antimicrobial resistance (AMR). Dr Clive Mason — Programme Director for AMR at LifeArc, a self-funded, not-for-profit medical research charity — says better funding can help bridge the gap between research labs and clinics to create new...
-
s Sponsored
A global hub supporting research into antimicrobial resistance
The global fight against antimicrobial resistance is being taken to a new level by a ‘neutral broker’ organisation that is providing evidence to help set priorities and maximise the impact of resources and efforts invested into AMR research. The Global AMR Research and Development (R&D) Hub was launched following a call from G20 Leaders to...
-
s Sponsored
Why a new certification is setting the standard for antibiotic manufacturers
Antibiotic manufacturers can be awarded a new certification — if they demonstrate that they are minimising the risk of antibiotic waste entering the environment. The British Standards Institution (BSI) has developed a new certification programme called the ‘BSI Kitemark™ for minimised risk of antimicrobial resistance.’ Potential risks in antibiotic manufacturing It’s been well-publicised that the...
-
Coalescing the global AMR voices for UNGA High-Level Meeting in 2024
The last year has seen several efforts to galvanise the AMR community towards seizing the unique opportunity of the United Nations General Assembly (UNGA) High-Level Meeting (HLM) on AMR scheduled for 2024. The President of the General Assembly has appointed Barbados and Malta as co-facilitators to present options and modalities for the HLM in collaboration...
-
s Sponsored
Fighting AMR requires scientific, political and social organisations to closely collaborate
AMR is recognised as a major threat to human health, with nearly 5 million people dying each year from infections caused by antimicrobial-resistant bacteria. This is estimated to rise to 10 million by 2050. The development of resistance is driven by the misuse of antibiotics in humans and animals. Resistant bacteria can then spread through...